TDRD9
protein-codingtudor domain containing 9, the group of Tudor domain containing
Gene summary
Predicted to enable ATP hydrolysis activity; RNA binding activity; and helicase activity. Involved in spermatogenesis. Located in cytoplasm and nucleus. Implicated in spermatogenic failure 30. [provided by Alliance of Genome Resources, Jul 2025]
- C14orf75
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~124.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0020851
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018393
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0020851
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Genitourinary
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TDRD9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_153046.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 13 | 2 | 19 | ||
| missense | 205 | 9 | 4 | 218 | ||
| nonsense | 1 | 2 | 4 | 7 | ||
| start loss | 0 | |||||
| frameshift | 4 | 4 | 8 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 5 | 6 | 216 | 22 | 6 | 255 |
Highest pathogenic variant AF is 0.0003444117
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_694591.2 | 36 | MANE Select | |
| Ensembl | ENSP00000387303.4 | 36 | MANE Select | |
| Ensembl | ENSP00000451637.1 | 26 | Standard | |
| Ensembl | ENSP00000637870.1 | 35 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- PIWI-interacting RNA (piRNA) biogenesis
- Gene Silencing by RNA
Biological Process
- male meiotic nuclear division
- male meiosis I
- multicellular organism development
- spermatogenesis
- fertilization
Molecular Function
- RNA binding
- ATP binding
- ATPase activity
- ATP-dependent 3'-5' RNA helicase activity
Cellular Component
- nucleus
- cytoplasm
- piP-body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000409874
- Coding exons
- 36
- Length
- 124206
- Individuals with no LoFs
- 125472
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 120
- Defined
- 125592
- p
- 0.000478
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.36 | 530 | 706 | 0.750 | 0.0000382 | 9036 |
| Missense (PolyPhen) | 149 | 227.94 | 0.65367 | 2830 | ||
| Synonymous | 0.0220 | 261 | 261 | 0.998 | 0.0000155 | 2590 |
| Loss of Function | 4.03 | 36 | 73.2 | 0.492 | 0.00000370 | 938 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00058 | 0.00058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00075 | 0.00071 | rare |
| Finnish | 0.00039 | 0.00037 | rare |
| European (Non-Finnish) | 0.00051 | 0.00050 | rare |
| South Asian | 0.00034 | 0.00033 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: ATP-binding RNA helicase required during spermatogenesis (PubMed:28536242). Required to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Acts downstream of piRNA biogenesis: exclusively required for transposon silencing in the nucleus, suggesting that it acts as a nuclear effector in the nucleus together with PIWIL4. {ECO:0000250|UniProtKB:Q14BI7, ECO:0000269|PubMed:28536242}.;
- Disease
- DISEASE: Note=Defects in TDRD9 may be a cause of non-obstructive azoospermia, a disorder characterized by the absence of sperm. Female fertility is not affected. {ECO:0000269|PubMed:28536242}.;
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- LoFtool
- 0.988
- RVIS EVS
- -0.19
- RVIS percentile EVS
- 39.28
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.155
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |